<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; design</title>
	<atom:link href="http://www.tapanray.in/tag/design/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>‘Design Thinking’: Translating Struggles into Positive Outcomes in Pharma</title>
		<link>http://www.tapanray.in/design-thinking-translating-struggles-into-positive-outcomes-in-pharma/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=design-thinking-translating-struggles-into-positive-outcomes-in-pharma</link>
		<comments>http://www.tapanray.in/design-thinking-translating-struggles-into-positive-outcomes-in-pharma/#comments</comments>
		<pubDate>Mon, 24 Sep 2018 00:00:38 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[company]]></category>
		<category><![CDATA[culture]]></category>
		<category><![CDATA[design]]></category>
		<category><![CDATA[Design thinking]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[organization]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[problem]]></category>
		<category><![CDATA[prototype]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[solution]]></category>
		<category><![CDATA[solving]]></category>
		<category><![CDATA[struggles]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[thinking]]></category>
		<category><![CDATA[UCB]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9196</guid>
		<description><![CDATA[Problems of various nature will keep coming on business, as long as long as one remains in the business. It doesn’t spare anyone in the organization – from the very top to right up to the very bottom. All is &#8230; <a href="http://www.tapanray.in/design-thinking-translating-struggles-into-positive-outcomes-in-pharma/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/design-thinking-translating-struggles-into-positive-outcomes-in-pharma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Power Of Color And Design In Pharma Branding</title>
		<link>http://www.tapanray.in/the-power-of-color-and-design-in-pharma-branding/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-power-of-color-and-design-in-pharma-branding</link>
		<comments>http://www.tapanray.in/the-power-of-color-and-design-in-pharma-branding/#comments</comments>
		<pubDate>Mon, 16 Nov 2015 00:00:18 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[blue]]></category>
		<category><![CDATA[branding]]></category>
		<category><![CDATA[color]]></category>
		<category><![CDATA[design]]></category>
		<category><![CDATA[Dr. Reddy's]]></category>
		<category><![CDATA[DRL]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[nexium]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[power]]></category>
		<category><![CDATA[purple]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Requip]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[viagra]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7274</guid>
		<description><![CDATA[On November 06, 2015, the District Court of Delaware of the United States (US) passed a temporary restraining order barring Dr. Reddy&#8217;s Laboratories (DRL) from selling in the US its generic version of AstraZeneca’s blockbuster anti-ulcerant drug Nexium, with immediate &#8230; <a href="http://www.tapanray.in/the-power-of-color-and-design-in-pharma-branding/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-power-of-color-and-design-in-pharma-branding/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
